"10.1371_journal.pone.0092314","plos one","2014-03-25T00:00:00Z","Yasuaki Nakagawa; Toshio Nishikimi; Koichiro Kuwahara; Shinji Yasuno; Hideyuki Kinoshita; Yoshihiro Kuwabara; Kazuhiro Nakao; Takeya Minami; Chinatsu Yamada; Kenji Ueshima; Yoshihiro Ikeda; Hiroyuki Okamoto; Kazukiyo Horii; Kiyoshi Nagata; Kenji Kangawa; Naoto Minamino; Kazuwa Nakao","Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan; Department of EBM Research, Kyoto University Hospital, Institute for Advancement of Clinical and Translational Science, Kyoto, Japan; Medical corporation, Ikeda Clinic, Kyoto, Japan; Diagnostics Division, Shionogi & Co., Ltd, Oska, Japan; Department of Biochemistry, National Cerebral and Cardiovascular Center Research Institute, Fujishirodai, Suita, Osaka, Japan; Department of Molecular Pharmacology, National Cerebral and Cardiovascular Center Research Institute, Fujishirodai, Suita, Osaka, Japan","Conceived and designed the experiments: YN TN. Performed the experiments: YN TN K. Kuwahara SY HK YK Kazuhiro Nakao TM. Analyzed the data: CY KU YI. Contributed reagents/materials/analysis tools: HO KH K. Nagata K. Kangawa NM. Wrote the paper: TN YN. Supervision: Kazuwa Nakao.","HO, KH, and KN are employees of Shionogi & Co., Ltd. Shionogi Company previously developed the BNP kit used in this study (Patent name: monoclonal antibody recognizing for C-terminal region of BNP and Patent number: 665850) and intend to develop a new assay kit for proBNP. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","03","Yasuaki Nakagawa","YN",17,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
